Holzer & Holzer, LLC reminds shareholders that the class action filed against BioVie Inc. has an upcoming March 19, 2024 Lead Plaintiff deadline.

(NASDAQ:BIVI)

ATLANTA, GEORGIA, UNITED STATES, March 6, 2024 /EINPresswire.com/ — Holzer & Holzer, LLC reminds shareholders that the class action filed against BioVie Inc. (“BioVie” or the “Company”) (NASDAQ: BIVI) in the United States District Court for the District of Nevada, Case No. 3:24-cv-00035, has an upcoming March 19, 2024 Lead Plaintiff deadline.

The lawsuit alleges Defendants made materially false and misleading statements and/or failed to disclose material information regarding the Company’s business, operations, compliance, and prospects, including allegations that: (1) the ongoing COVID-19 pandemic caused “limited access” to clinical trial sites, significantly affecting the Company’s ability to conduct proper oversight of the clinical trial; (2) due to the “limited access” to the clinical trial sites, the trial was at higher risk of having “significant deviation from protocol and Good Clinical Practice (GCP) violations” and “anomalous data;” (3) the Company was experiencing issues with the CRO(s) it had retained, creating greater risk of the trial being in non-compliance with GCPs; (4) the Company had identified “higher than expected levels of deviations” in the data; (5) due to a “highly unusual level of suspected improprieties” there was a heightened risk a majority of the clinical trial subjects would be excluded; and (6) as a result of the exclusions, there was a heightened material risk that the clinical trial would “not achieve statistical significance.”

If you bought BioVie shares between August 5, 2021 and November 29, 2023, and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888)-508-6832 or, you may visit the firm’s website at www.holzerlaw.com/case/biovie/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is March 19, 2024.

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021 and 2022, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content. 

Corey Holzer
Holzer & Holzer, LLC
+1 770-392-0090
cholzer@holzerlaw.com

https://www.einpresswire.com/rss/TjzOvfsYMgM6ikXo

Leave a Reply